Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements

Implications in infant leukemia

Anna M. Azarova, Ren K. Lin, Yuan Chin Tsai, Leroy F. Liu, Chao P. Lin, Yi Lisa Lyu

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Genistein is a bioflavonoid enriched in soy products. However, high levels of maternal soy consumption have been linked to the development of infant leukemia ALL and AML. The majority of infant leukemia is linked to mixed lineage leukemia gene (MLL) translocations. Previous studies have implicated topoisomerase II (Top2) in genistein-induced infant leukemia. In order to understand the roles of the two Top2 isozymes in and the molecular mechanism for genistein-induced infant leukemia, we carried out studies in vitro using purified recombinant human Top2 isozymes, as well as studies in cultured mouse myeloid progenitor cells (32Dc13) and Top2β knockout mouse embryonic fibroblasts (MEFs). First, we showed that genistein efficiently induced both Top2α and Top2β cleavage complexes in the purified system as well as in cultured mouse cells. Second, genistein induced proteasomal degradation of Top2β in 32Dc13 cells. Third, the genistein-induced DNA double-strand break (DSB) signal, γ-H2AX, was dependent on the Top2β isozyme and proteasome activity. Fourth, the requirement for Top2β and proteasome activity was mirrored in genistein-induced DNA sequence rearrangements, as monitored by a DNA integration assay. Together, our results suggest a model in which genistein-induced Top2β cleavage complexes are processed by proteasome, leading to the exposure of otherwise Top2β-concealed DSBs and subsequent chromosome rearrangements, and implicate a major role of Top2β and proteasome in genistein-induced infant leukemia.

Original languageEnglish
Pages (from-to)66-71
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume399
Issue number1
DOIs
Publication statusPublished - Aug 2010
Externally publishedYes

Fingerprint

Gene Rearrangement
Genistein
DNA sequences
Proteasome Endopeptidase Complex
Leukemia
Isoenzymes
Myeloid Progenitor Cells
Type II DNA Topoisomerase
Double-Stranded DNA Breaks
DNA
Fibroblasts
Chromosomes
Child Development
Flavonoids
Knockout Mice
Cultured Cells
Assays
Genes
Mothers
Degradation

Keywords

  • Genistein
  • Infant leukemia
  • MLL translocation
  • Proteasome
  • Topoisomerase IIbeta

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements : Implications in infant leukemia. / Azarova, Anna M.; Lin, Ren K.; Tsai, Yuan Chin; Liu, Leroy F.; Lin, Chao P.; Lyu, Yi Lisa.

In: Biochemical and Biophysical Research Communications, Vol. 399, No. 1, 08.2010, p. 66-71.

Research output: Contribution to journalArticle

@article{461307e4456a4e58a6830c0cce407bdc,
title = "Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia",
abstract = "Genistein is a bioflavonoid enriched in soy products. However, high levels of maternal soy consumption have been linked to the development of infant leukemia ALL and AML. The majority of infant leukemia is linked to mixed lineage leukemia gene (MLL) translocations. Previous studies have implicated topoisomerase II (Top2) in genistein-induced infant leukemia. In order to understand the roles of the two Top2 isozymes in and the molecular mechanism for genistein-induced infant leukemia, we carried out studies in vitro using purified recombinant human Top2 isozymes, as well as studies in cultured mouse myeloid progenitor cells (32Dc13) and Top2β knockout mouse embryonic fibroblasts (MEFs). First, we showed that genistein efficiently induced both Top2α and Top2β cleavage complexes in the purified system as well as in cultured mouse cells. Second, genistein induced proteasomal degradation of Top2β in 32Dc13 cells. Third, the genistein-induced DNA double-strand break (DSB) signal, γ-H2AX, was dependent on the Top2β isozyme and proteasome activity. Fourth, the requirement for Top2β and proteasome activity was mirrored in genistein-induced DNA sequence rearrangements, as monitored by a DNA integration assay. Together, our results suggest a model in which genistein-induced Top2β cleavage complexes are processed by proteasome, leading to the exposure of otherwise Top2β-concealed DSBs and subsequent chromosome rearrangements, and implicate a major role of Top2β and proteasome in genistein-induced infant leukemia.",
keywords = "Genistein, Infant leukemia, MLL translocation, Proteasome, Topoisomerase IIbeta",
author = "Azarova, {Anna M.} and Lin, {Ren K.} and Tsai, {Yuan Chin} and Liu, {Leroy F.} and Lin, {Chao P.} and Lyu, {Yi Lisa}",
year = "2010",
month = "8",
doi = "10.1016/j.bbrc.2010.07.043",
language = "English",
volume = "399",
pages = "66--71",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements

T2 - Implications in infant leukemia

AU - Azarova, Anna M.

AU - Lin, Ren K.

AU - Tsai, Yuan Chin

AU - Liu, Leroy F.

AU - Lin, Chao P.

AU - Lyu, Yi Lisa

PY - 2010/8

Y1 - 2010/8

N2 - Genistein is a bioflavonoid enriched in soy products. However, high levels of maternal soy consumption have been linked to the development of infant leukemia ALL and AML. The majority of infant leukemia is linked to mixed lineage leukemia gene (MLL) translocations. Previous studies have implicated topoisomerase II (Top2) in genistein-induced infant leukemia. In order to understand the roles of the two Top2 isozymes in and the molecular mechanism for genistein-induced infant leukemia, we carried out studies in vitro using purified recombinant human Top2 isozymes, as well as studies in cultured mouse myeloid progenitor cells (32Dc13) and Top2β knockout mouse embryonic fibroblasts (MEFs). First, we showed that genistein efficiently induced both Top2α and Top2β cleavage complexes in the purified system as well as in cultured mouse cells. Second, genistein induced proteasomal degradation of Top2β in 32Dc13 cells. Third, the genistein-induced DNA double-strand break (DSB) signal, γ-H2AX, was dependent on the Top2β isozyme and proteasome activity. Fourth, the requirement for Top2β and proteasome activity was mirrored in genistein-induced DNA sequence rearrangements, as monitored by a DNA integration assay. Together, our results suggest a model in which genistein-induced Top2β cleavage complexes are processed by proteasome, leading to the exposure of otherwise Top2β-concealed DSBs and subsequent chromosome rearrangements, and implicate a major role of Top2β and proteasome in genistein-induced infant leukemia.

AB - Genistein is a bioflavonoid enriched in soy products. However, high levels of maternal soy consumption have been linked to the development of infant leukemia ALL and AML. The majority of infant leukemia is linked to mixed lineage leukemia gene (MLL) translocations. Previous studies have implicated topoisomerase II (Top2) in genistein-induced infant leukemia. In order to understand the roles of the two Top2 isozymes in and the molecular mechanism for genistein-induced infant leukemia, we carried out studies in vitro using purified recombinant human Top2 isozymes, as well as studies in cultured mouse myeloid progenitor cells (32Dc13) and Top2β knockout mouse embryonic fibroblasts (MEFs). First, we showed that genistein efficiently induced both Top2α and Top2β cleavage complexes in the purified system as well as in cultured mouse cells. Second, genistein induced proteasomal degradation of Top2β in 32Dc13 cells. Third, the genistein-induced DNA double-strand break (DSB) signal, γ-H2AX, was dependent on the Top2β isozyme and proteasome activity. Fourth, the requirement for Top2β and proteasome activity was mirrored in genistein-induced DNA sequence rearrangements, as monitored by a DNA integration assay. Together, our results suggest a model in which genistein-induced Top2β cleavage complexes are processed by proteasome, leading to the exposure of otherwise Top2β-concealed DSBs and subsequent chromosome rearrangements, and implicate a major role of Top2β and proteasome in genistein-induced infant leukemia.

KW - Genistein

KW - Infant leukemia

KW - MLL translocation

KW - Proteasome

KW - Topoisomerase IIbeta

UR - http://www.scopus.com/inward/record.url?scp=77955562548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955562548&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.07.043

DO - 10.1016/j.bbrc.2010.07.043

M3 - Article

VL - 399

SP - 66

EP - 71

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -